A Study of Brenipatide in Participants With Opioid Use Disorder
for Opioid Use Disorder
38 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07420283·Phase 2·Recruiting·Listed Feb 2026
University of Virginia Health System
Clinical research site in Charlottesville, Virginia · 1215 LEE ST, CHARLOTTESVILLE, VA 22908-0001 · (434) 924-0000
As of September 2026, 58 paid clinical trials are recruiting at University of Virginia Health System in Charlottesville, Virginia. Active studies at this site cover conditions such as ARDS, ARDS (Acute Respiratory Distress Syndrome) and Acute Respiratory Distress Syndrome. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
New trial at University of Virginia Health System? We'll email you when one opens.
Recruiting clinical trials at University of Virginia Health System (58)
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
for Breast Neoplasms
34 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: Female·Age: 18+
Code: NCT07287098·Phase 2·Recruiting·Listed Dec 2025
A Study of Buntanetap in Participants With PD
for Parkinson's Disease (PD)
27 locations incl. Birmingham
Sponsor: Annovis Bio Inc.
Sex: All·Age: 40 - 85
Code: NCT07284784·Phase 2, Phase 3·Recruiting·Listed Dec 2025
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for Ovarian Cancer
48 locations incl. Anchorage
Sponsor: Incyte Corporation
Sex: Female·Age: 18+
Code: NCT07214779·Phase 3·Recruiting·Listed Oct 2025
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
91 locations incl. Huntsville
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06890598·Phase 3·Recruiting·Listed Mar 2025
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
88 locations incl. Huntsville
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06119581·Phase 3·Recruiting·Listed Nov 2023
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for Parkinson's Disease
50 locations incl. Birmingham
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 85
Code: NCT07174310·Phase 3·Recruiting·Listed Sep 2025
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for Metastatic Castration-resistant Prostate Cancer (mCRPC)
55 locations incl. Tucson
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06136650·Phase 3·Recruiting·Listed Nov 2023
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for Solid Tumors
42 locations incl. Tucson
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT03486873·Phase 3·Recruiting·Listed Apr 2018
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
for Lumbar Spinal Stenosis
2369 locations incl. Athens
Sponsor: Stryker Instruments
Sex: All·Age: 18+
Code: NCT03072927·Recruiting·Listed Mar 2017
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
for Prostate Cancer Metastatic
33 locations incl. Palo Alto
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06136624·Phase 3·Recruiting·Listed Nov 2023
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for Neoplasms
78 locations incl. Birmingham
Sponsor: Celgene
Sex: All·Age: All ages
Code: NCT03435796·Phase 2, Phase 3·Recruiting·Listed Feb 2018
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for Obstructive Hypertrophic Cardiomyopathy
48 locations incl. Anchorage
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT05489705·Recruiting·Listed Aug 2022
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
for Low Grade Serous Ovarian Cancer
36 locations incl. Phoenix
Sponsor: Verastem, Inc.
Sex: Female·Age: 18+
Code: NCT06072781·Phase 3·Recruiting·Listed Oct 2023
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
for Non-Small Cell Lung Cancer
26 locations incl. Irvine
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07100080·Phase 2, Phase 3·Recruiting·Listed Aug 2025
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
for Urothelial Cancer
33 locations incl. Gilbert
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07106762·Phase 2, Phase 3·Recruiting·Listed Aug 2025
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
for Endometrial Adenocarcinoma
42 locations incl. Phoenix
Sponsor: Acrivon Therapeutics
Sex: Female·Age: 18+
Code: NCT05548296·Phase 2·Recruiting·Listed Sep 2022
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
for Kidney Disease, Chronic
45 locations incl. Huntsville
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06531824·Phase 3·Recruiting·Listed Aug 2024
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
for Progressive Pulmonary Fibrosis
74 locations incl. Birmingham
Sponsor: United Therapeutics
Sex: All·Age: 18+
Code: NCT05943535·Phase 3·Recruiting·Listed Jul 2023
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
for Tricuspid Regurgitation
46 locations incl. Irvine
Sponsor: Edwards Lifesciences
Sex: All·Age: 18+
Code: NCT04097145·Recruiting·Listed Sep 2019
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
for Abdominal Aortic Aneurysm
28 locations incl. Loma Linda
Sponsor: Medtronic Cardiovascular
Sex: All·Age: 20+
Code: NCT05378347·Recruiting·Listed May 2022
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
for Acute Respiratory Distress Syndrome (ARDS)
40 locations incl. Birmingham
Sponsor: PPD Development, LP
Sex: All·Age: 18+
Code: NCT06703073·Phase 2·Recruiting·Listed Nov 2024
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
for Acute Respiratory Distress Syndrome (ARDS)
40 locations incl. Birmingham
Sponsor: PPD Development, LP
Sex: All·Age: 18+
Code: NCT06701656·Phase 2·Recruiting·Listed Nov 2024
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
for Acute Respiratory Distress Syndrome (ARDS)
40 locations incl. Birmingham
Sponsor: PPD Development, LP
Sex: All·Age: 18+
Code: NCT06701669·Phase 2·Recruiting·Listed Nov 2024
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
for Acute Respiratory Distress Syndrome (ARDS)
40 locations incl. Birmingham
Sponsor: PPD Development, LP
Sex: All·Age: 18+
Code: NCT06701682·Phase 2·Recruiting·Listed Nov 2024
Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
for Duchenne Muscular Dystrophy
31 locations incl. Phoenix
Sponsor: Catalyst Pharmaceuticals, Inc.
Sex: Male·Age: 2+
Code: NCT06564974·Recruiting·Listed Aug 2024
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
for Spinal Muscular Atrophy (SMA)
42 locations incl. Phoenix
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: All ages
Code: NCT04174157·Recruiting·Listed Nov 2019
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
for Advanced Urothelial Cancer
10 locations incl. Duarte
Sponsor: Generate Biomedicines
Sex: All·Age: 18+
Code: NCT07484022·Phase 1·Recruiting·Listed Mar 2026
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
for MASH - Metabolic Dysfunction-Associated Steatohepatitis
16 locations incl. La Jolla
Sponsor: Madrigal Pharmaceuticals, Inc.
Sex: All·Age: 18 - 75
Code: NCT07335601·Phase 2·Recruiting·Listed Jan 2026
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
for Small Cell Lung Cancer Extensive Stage
13 locations incl. Santa Rosa
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT07227597·Phase 1, Phase 2·Recruiting·Listed Nov 2025
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
for Advanced Solid Tumor
7 locations incl. Atlanta
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18+
Code: NCT04104776·Phase 1, Phase 2·Recruiting·Listed Sep 2019
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
for Type 1 Diabetes
22 locations incl. San Francisco
Sponsor: SAb Biotherapeutics, Inc.
Sex: All·Age: 5 - 40
Code: NCT07187531·Phase 2·Recruiting·Listed Sep 2025
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
for Complex Cardiovascular Surgery With Cardiopulmonary Bypass
16 locations incl. Los Angeles
Sponsor: CSL Behring
Sex: All·Age: 18+
Code: NCT07094087·Phase 3·Recruiting·Listed Jul 2025
The Ailliance Post-Market Clinical Study
for Spinal Deformity
22 locations incl. Tucson
Sponsor: Medtronic Spinal and Biologics
Sex: All·Age: 18+
Code: NCT05856370·Recruiting·Listed May 2023
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
for Idiopathic Pulmonary Fibrosis
15 locations incl. Birmingham
Sponsor: Boehringer Ingelheim
Sex: All·Age: 40+
Code: NCT07036523·Phase 2·Recruiting·Listed Jun 2025
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
for Crohn Disease
12 locations incl. Bristol
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: All ages
Code: NCT06651281·Phase 3·Recruiting·Listed Oct 2024
A Study of BI 3810944 in Patients With Advanced Cancer
for Solid Tumours
4 locations incl. Louisville
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07224425·Phase 1·Recruiting·Listed Nov 2025
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
for Congenital Adrenal Hyperplasia
9 locations incl. San Francisco
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All·Age: 1 - 17
Code: NCT07159841·Phase 2, Phase 3·Recruiting·Listed Sep 2025
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
for Ovarian Cancer Recurrent
9 locations incl. New Haven
Sponsor: Merck Sharp & Dohme LLC
Sex: Female·Age: 18+
Code: NCT06843447·Phase 1, Phase 2·Recruiting·Listed Feb 2025
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
for Amyotrophic Lateral Sclerosis
6 locations incl. Birmingham
Sponsor: AB Science
Sex: All·Age: 18 - 81
Code: NCT03127267·Phase 3·Recruiting·Listed Apr 2017
Showing the 40 most relevant of 58 recruiting trials at this site. Browse all with filters →
Get new-trial alerts for University of Virginia Health System
We'll email you whenever a new clinical trial starts recruiting at this research site in Charlottesville, VA. Unsubscribe anytime.
More research sites in Charlottesville
- University of Virginia (185 trials)
- University of Virginia Cancer Center (84 trials)
- University of Virginia Medical Center (22 trials)
- University of Virginia Comprehensive Cancer Center (13 trials)
- UVA Health (8 trials)
- Charlottesville Medical Research (7 trials)
- UVA Comprehensive Cancer Center (5 trials)
- UVA Medical Center (5 trials)
- University of Virginia Center for Diabetes Technology (5 trials)
- University of Virginia School of Medicine (5 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Charlottesville, VA · Virginia clinical trials